免疫组织化学市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

免疫组织化学市场按产品(抗体、设备、试剂)、应用和地理位置进行细分。

免疫组织化学市场快照

Immunohistochemistry Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.3 %
Immunohistochemistry Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

研究的免疫组织化学市场预计在预测期内将以近 7.3% 的复合年增长率增长。导致市场增长的主要因素是癌症发病率的增加,因为免疫组织化学主要用于诊断癌症和包括抗原抗体反应在内的其他疾病。根据美国国立卫生研究院 (NIH) 的数据,2018 年,美国估计将发现 1,735,350 例新的癌症病例,将有 609,640 人死于该病。此外,老年人口的增加和诊断中心数量的增加正在推动免疫组织化学市场的增长。此外,生物技术公司对研发项目的投资不断增加也影响着市场的增长。然而,

报告范围

根据报告的范围,免疫组织化学 (IHC) 是一种通过利用抗体与生物组织中的抗原特异性结合的原理来检测组织切片细胞中抗原或半抗原的技术。可以用不同的方法观察抗体-抗原结合。酶,如辣根过氧化物酶或碱性磷酸酶,通常用于催化产生颜色的反应。这份关于免疫组织化学市场的报告按产品、应用和地理细分。

By Product
Antibodies
Equipment
Kits and Reagents
By Application
Diagnostics
Drug Testing
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

诊断部门占免疫组织化学市场的最大份额。

这一细分市场的很大一部分归功于癌症的日益突出,以及免疫组织化学在癌症、传染病、心血管疾病和其他疾病的诊断中的广泛应用。根据英国癌症研究中心的数据,全世界最常见的四种癌症是肺癌、女性乳腺癌、肠癌和前列腺癌。这四种占全球诊断出的所有癌症的十分之四以上。到 2040 年,全球每年将有 2750 万新癌症病例,2018 年全球将有 960 万人死于癌症。此外,更容易患传染病和其他慢性疾病的老年人口不断增加,全球诊断中心的数量也在增加是推动市场增长的其他少数因素。

Immunohistochemistry Market Trends

北美在市场上占主导地位,预计在预测期内也会如此

在整个预测期内,预计北美将主导整个市场。市场增长是由于该地区主要参与者的存在、癌症和其他慢性病的高发病率等因素,成熟的医疗保健基础设施是其在市场中占有很大份额的一些关键因素。此外,有益的政府举措和研究合作伙伴数量的增加是预计增加市场增长的一些驱动因素。由于支持性医疗保健政策、大量患者和发达的医疗保健市场,美国在该地区的份额最大。根据美国癌症协会的数据,2019 年,美国估计有 1,762,450 例新诊断的癌症病例和 606,880 例癌症死亡病例。据统计,

Immunohistochemistry Market Analysis

竞争格局

免疫组织化学市场竞争适度,由几个主要参与者组成。目前主导市场的一些公司是 F. Hoffmann-LA Roche AG、Agilent Technologies, Inc.、Thermo Fisher Scientific Inc.、Merck Millipore、Abcam PLC、Bio-Rad Laboratories, Inc.、Perkinelmer, Inc.、 Cell Signaling Technology, Inc., Bio SB。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Cancer

      2. 4.2.2 Rapidly Increasing Geriatric Population

      3. 4.2.3 Increasing Healthcare Spending

    3. 4.3 Market Restraints

      1. 4.3.1 Limited Reimbursement Policies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Antibodies

      2. 5.1.2 Equipment

      3. 5.1.3 Kits and Reagents

    2. 5.2 By Application

      1. 5.2.1 Diagnostics

      2. 5.2.2 Drug Testing

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 F. Hoffmann-LA Roche AG

      2. 6.1.2 Agilent Technologies, Inc.

      3. 6.1.3 Thermo Fisher Scientific Inc.

      4. 6.1.4 Merck KGaA

      5. 6.1.5 Abcam PLC

      6. 6.1.6 Bio-Rad Laboratories, Inc.

      7. 6.1.7 Perkinelmer, Inc.

      8. 6.1.8 Cell Signaling Technology, Inc.

      9. 6.1.9 Bio SB

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Immunohistochemistry Market market is studied from 2018 - 2026.

The Immunohistochemistry Market is growing at a CAGR of 7.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

F. Hoffmann-LA Roche AG, Agilent Technologies, Inc.`, Thermo Fisher Scientific Inc., Merck KGaA, Abcam PLC are the major companies operating in Immunohistochemistry Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!